Dr Hiren Mandaliya is a medical oncologist and a fellow of The Royal Australasian College of Physicians. Dr Mandaliya also has a special interest in cancer research.

Following attainment of his fellowship, Dr Mandaliya joined Calvary Mater Newcastle as Clinical Trial Fellow in 2018 to broaden his research experience. He has been involved in multiple Phase I, Phase II, Phase III and investigator initiated trials as an investigator. He works with leading clinicians, scientists and researchers in the field. Since 2019, he has been appointed as staff specialist medical oncologist at Calvary Mater Newcastle. He is a visiting medical officer (VMO) medical oncologist at a number of private hospitals including Lake Macquarie Private Hospital.

Dr Mandaliya has a clinical-research interest in the field of lung cancer, mesothelioma, gynaecological cancers (including ovarian cancer, endometrial cancers, cervical cancers and others) and breast cancers. He also treats melanoma, gastrointestinal cancers, genitourinary cancers, head & neck cancers. Dr Mandaliya is a regular member of the multidisciplinary tumour board meeting at John Hunter Hospital and Calvary Mater Newcastle.

Dr Mandaliya completed his MBBS and MD (Internal Medicine) in India and came to Australia in 2009. Dr Mandaliya is a recipient of prestigious 'Conquer Cancer Foundation of ASCO Merit Award 2019' for his research work.

Currently he has been involved with various collaborative research projects with scientists at Calvary Mater Newcastle and University of Newcastle. Dr Mandaliya has a strong commitment to medical education and is affiliated as a Conjoint lecturer with the University of Newcastle.

Dr Mandaliya has conducted research projects for breast, lung, gastrointestinal and other malignancies. His research work and interests have also focused on psychosocial aspects of cancer survivors and medical students’ education. He has presented his research results at various local, national and international conferences such as ASCO (American Society of Clinical Oncology) and ESMO (European Society of Medical Oncology). Dr Mandaliya has also published his research in various peer-reviewed journals.

He is a member of Medical Oncology Group of Australia (MOGA), Australia New Zealand Gynaecological Oncology Group (ANZGOG), Thoracic Oncology Group Australasia (TOGA), Australasian Gastro-Intestinal Trials Group (AGITG), Breast Cancer Trials group, ASCO and ESMO.